Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratio. En savoir plus sur Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratio.
Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. En savoir plus sur Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification.
Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement. En savoir plus sur Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement.
Indirect evidence for a Fc gamma receptor on guinea pig platelets: guinea pig represents a promising species for the investigation of human disorders with immune platelet activation. En savoir plus sur Indirect evidence for a Fc gamma receptor on guinea pig platelets: guinea pig represents a promising species for the investigation of human disorders with immune platelet activation.
APOE genotyping: comparison of three methods. En savoir plus sur APOE genotyping: comparison of three methods.
Pellets for oral administration of low-molecular-weight heparin. En savoir plus sur Pellets for oral administration of low-molecular-weight heparin.
Granules in the improvement of oral heparin bioavailability. En savoir plus sur Granules in the improvement of oral heparin bioavailability.
Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration. En savoir plus sur Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
Speciation of arsenic in urine following intravenous administration of arsthinol in mice. En savoir plus sur Speciation of arsenic in urine following intravenous administration of arsthinol in mice.
Development of microemulsion of mitotane for improvement of oral bioavailability. En savoir plus sur Development of microemulsion of mitotane for improvement of oral bioavailability.
